Fatal Thrombocytopenia and Liver Failure Associated with Carboplatin Therapy-Reference-Cited by-同舟云学术

Fatal Thrombocytopenia and Liver Failure Associated with Carboplatin Therapy

Published:1991-01 Issue:3 Volume:9 Page:263-268
ISSN:0735-7907
Container-title:Cancer Investigation
language:en
Short-container-title:Cancer Investigation

Author:

Hruban Ralph H.,Sternberg Stephen S.,Meyers Paul,Fleisher Martin,Menendez-Botet Celia,Boitnott John K.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/07357909109021323

Reference29 articles.

1. ANTITUMOR, TOXIC AND BIOCHEMICAL PROPERTIES OF CISPLATIN AND EIGHT OTHER PLATINUM COMPLEXES

2. Carboplatin (NSC-241-240): an active platinum analog for the treatment of squamous-cell carcinoma of the head and neck.

3. Annual Report to the Food and Drug Administration. December, 1988, CBDCA (NSC 241240, IND 19314), Division of Cancer Treatment, National Cancer Institute, Bethesda, MD

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Severe Case of Drug-Induced Liver Injury after Gemcitabine Administration: A Highly Probable Causality Grading as Assessed by the Updated RUCAM Diagnostic Scoring System;Case Reports in Hepatology;2020-10-01

2. Computed Tomography Liver Spleen Ratio as Predictive Marker of Liver Injury among Adult Filipina Early Breast Cancer Receiving Neoadjuvant Therapy from 2010-2016: A Six-Year Retrospective Study;International Journal of Cancer Research & Therapy;2017-12-15

3. Risk of severe acute liver injury among patients with brain cancer treated with temozolomide: a nested case-control study using the healthcore integrated research database;Journal of Neuro-Oncology;2017-07-17

4. Successful Paclitaxel Dose Adjustment in an Ovarian Cancer Patient with Paclitaxel and Carboplatin Chemotherapy-induced Liver Dysfunction;Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences);2015

5. Drug-Induced Liver Injury due to Cancer Chemotherapeutic Agents;Seminars in Liver Disease;2014-05-31